EMERG
ActiveSummary
EMERG has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,000 and a net result of €179,113. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 14% of 38,895 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 31 days late
2025
31-12
Financial
Highest result from 2019 to 2025net €179,113 ▲44.6%
Operating result €247,531, net result €179,113, both a record.
29-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
31-12
Financial
Equity above €200,000equity €245,384 ▲102%
A profit in every financial year since 2019 builds equity to €245,384.
25-10
NBB filing
Annual accounts filed
financial year 2023 · micro format · 86 days late
2023
31-12
Financial
Equity above €100,000equity €121,477 ▲31.6%
A profit in every financial year since 2019 builds equity to €121,477.
30-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 30 days late
2022
26-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 26 days late
2021
31-12
Financial
Equity above €100,000equity €136,073 ▲105%
A profit in every financial year since 2019 builds equity to €136,073.
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
31-12
Financial
Weakest financial yearnet €23,604 ▼35.5%
Net result drops to €23,604, the lowest in the series; recovery starts the following year.
09-11
NBB filing
Annual accounts filed
financial year 2019 · micro format · 101 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.